Trimedyne, Inc.

Cardiodyne, Inc.

Contracap, Inc.

University Patents, Inc.

Laserscope, Inc.

Biotek, Inc.

Cardiomedics, Inc.

Trimedyne Laser Systems, Inc.

Xtramedics, Inc.

Marvin P Loeb

L Dean Crawford

Hany M Hussein

Samuel M Shaolian

Robert A Goepp

Uwe E Freese

Vahid Saadatmanesh

Ginger Johnson

Stanislaw Sulek

Robert J Sullivan

Lawrence J Perkins

Randy P Graham

John P Burrell

Stephen Richard Ash

John F Perry

Sanford Damasco

James W Pergl

To Van Pham

Kenneth M Galt

Jeffrey J Giba

Randall J Blair

Vahid Saadat

James A Milburn

Harvey S Weiss

John McCallum

Douglas E Johnson

Arne M Olson

Lysing of fat cells in adipose tissue beneath the skin and liquefying the released fat is achieved by introducing a side-firing thermal energy device into the tissue to be irradiated, while thermal energy, such as laser energy, is emitted at a selected level for a selected period of time, depending on the volume to tissue to be irradiated. The side firing device is advanced into tissue and withdrawn and, while energy is emitted, is aimed separately at 3 o'clock and 9 o'clock and, is repetitively rotated through an arc of about 120&#xb0;, producing a bowtie-shaped irradiation pattern. The side firing device may be centered and sealingly held in position in a liposuction cannula by ribs extending inwardly from the interior of the liposuction cannula. At least one of the ribs has a channel for infusion of an irrigating liquid. The use of laser energy during lysis of fat cell membranes and the liquefaction of the released fat also produces photomechanical cross-linking of collagen, which shrinks and tightens the skin, reducing sagging of the skin after removal or absorption of the liquefied fat. Nucleus pulposus tissue can be vaporized in a similar manner.

Method for effective and uniform fat cell lysing and melting of the released fat

A method for treating patients suffering from left ventricular dysfunction is disclosed. The method involves applying, during diastole, for a time period of about one hour, at least five days each week for at least about six weeks, an incrementally increasing external therapeutic pressure sequentially to the patients' lower extremities from first the calves, then the thighs and last the buttocks. The initial hourly treatments are carried out at a peak diastolic/systolic pressure ratio (D/S Ratio) in the range of about 0.4:1 up to about 0.9:1, depending on the patient's left ventricular ejection fraction. The D/S Ratio is increased slightly during the next set of hourly treatments, the D/S Ratio is again increased slightly during the next following set of hourly treatments, the D/S Ratio is again increased slightly during the next set of hourly treatments, and finally the D/S Ratio is increased slightly and maintained during the remaining set of hourly treatments. The patient's cardiopulmonary functions preferably are monitored to determine if additional external therapeutic pressure treatments are needed.

External counter pulsation treatment

Circulatory assistance is provided in a non-invasive procedure safely and effectively using a microprocessor of an external counter pulsation device programmed to control the actuation of any or all of a plurality of valves, each of which is mounted on and in fluid communication with one of a plurality of individual inflatable bladders disposed in pockets within cuffs encasing the calves, thighs, buttocks, abdomen and/or chest of a person and an optional valve in fluid communication with the person's airway, in any desired sequence or order, toward the heart or toward the feet, either during diastole or systole, at desired inception times during the cardiac cycle, for selected durations and at chosen pressures, for treating a variety of cardiac, non-cardiac and circulatory conditions.

Devices and methods for non-invasively improving blood circulation

A method for treating patients suffering from left ventricular dysfunction, exhibited by a left ventricular ejection fraction (LVEF) less than normal, is disclosed. The method involves applying, during diastole, for a time period of about one hour, about five days each week for at least about seven weeks, an incrementally increasing therapeutic pressure to the patients' lower extremities, from the calves through the thighs and the buttocks. The hourly treatments are carried out at incrementally increasing peak diastolic/systolic pressure ratios (D/S Ratios) in the range of about 0.4:1 up to about 0.6:1 and thereafter at a D/S Ratio in the range of 0.5:1 to 1:1 for each consecutive hourly treatment, with the proviso that the average D/S Ratio over the entire treatment regimen does not exceed about 0.9:1.

A laser energy delivery device is provided that is suitable for irradiating a body tissue with relatively long wavelength laser energy in the presence of an aqueous liquid without significant absorption of the laser energy by the liquid. The device includes an elongate hollow sheath that has an open aperture at its distal end portion and closed at its proximal end, a laser energy conduit such as an optical fiber or hollow wave guide, within the sheath, the distal end of the conduit being disposed near the open aperture at the distal end portion of the sheath, and the proximal end of the conduit being adapted for connection to a source of long wavelength laser energy. The sheath also includes an inlet port, spaced from the proximal end of the sheath, and adapted to receive and deliver a biologically compatible gas through the sheath to a body tissue site in contact with the open distal end of the sheath. In use, the open aperture at the distal end portion of the sheath is positioned in contact with a body tissue site. Gas, such as carbon dioxide, infused through the sheath displaces an aqueous liquid from the region between the distal end portion of the sheath and the tissue. Laser energy emitted from the distal end portion of the conduit passes through the substantially liquid-free region at the distal end of the sheath and impinges on the tissue to be irradiated. The laser energy can be used to ablate, vaporize, coagulate or shrink tissue at the target zone without interference from aqueous liquids, which tend to absorb relatively large amounts of long wavelength laser energy and reduce the efficiency of tissue ablation.

Device and method for delivery of long wavelength laser energy to a tissue site

The invention relates to a catheter device including an optical fiber whose distal end is disposed within a hollow tube with a sharp or needle shaped distal end, which can penetrate tissue. The distal end of the optical fiber and the hollow tube are configured so as to emit, by refraction (total internal reflection) or reflection from a metal surface, laser energy at an angle of about 80&#xb0; to about 90&#xb0; relative to the longitudinal axis of the optical fiber and hollow tube. The hollow tube is mounted to a housing and may be surrounded by a sheath.

Devices and methods for directed, interstitial ablation of tissue

A laser energy delivery device and method are provided for irradiating a body tissue with relatively long wavelength laser energy in the presence of an aqueous liquid without significant absorption of the laser energy by the liquid. The device includes an elongate hollow sheath that is open at its distal end and closed at its proximal end, a laser energy conduit such as an optical fiber or hollow waveguide, within the sheath, the distal end of the conduit being disposed near the open distal end of the sheath, and the proximal end of the conduit being adapted for connection to a source of long wavelength laser energy. The sheath also includes an inlet port, spaced from the proximal end of the sheath, and adapted to receive and deliver a biologically compatible gas through the sheath to a body tissue site in contact with the open distal end of the sheath.

An optical fiber device for ablating a channel through a plaque deposit or a clot in a blood vessel is described. Laser energy is transmitted through one or a bundle of optical fibers to a quartz or fused silica cylinder, whose distal end surface has been made into a desired shape and sandblasted or carbon coated or both. The cylinder is received with a pocket defined in a sheath which surrounds the optical fibers. Moreover, the cylinder includes a circumferential recess and the sheath includes a circumferential rib which engages into the recess for securing the lens in the pocket. In one embodiment, the cylinder has a cavity formed therein and the distal end of the optical fiber extends into the cavity. In a further embodiment, the device is adapted to be guided along a wire extending through the pocket and an aperture defined in the sheath and/or a channel defined in the cylinder.

Laser channeling devices

The invention relates to a catheter device including an optical fiber whose distal end is disposed within a hollow tube with a sharp or syringe shaped distal end, which may be inserted into tissue. The distal end of the optical fiber and the hollow tube are configured so as to emit, by refraction (total internal reflection) or reflection from a metal surface, laser energy at an angle of about 80&deg; to about 90&deg; relative to the longitudinal axis of the optical fiber and hollow tube. A first fluid channel within the distal end portion of the tube enables fluid to be infused to cool the distal end of the tube and to cool and clean the emission face of the optical fiber. A second, relatively larger diameter fluid channel in the tube enables the fluid, flowing through said first channel along with hot gasses from the vaporization of tissue, to exit the device through a second port in the tube, away from the tissue being treated. A vacuum can be applied to the second fluid channel to more effectively remove the infused, cooling fluid and hot gasses from the tissue being treated. Alternatively, the tube can incorporate a distal end portion which can be articulated to allow the insertion of the device into tissue perpendicular to the tissue's surface, from which laser energy can be emitted forwardly.

A catheter device suitable for shrinking chordae tendineae of the human heart is provided having an energy conduit and a positioning device that facilitates the delivery of thermal energy, including coherent (laser) or non-coherent light, RF, microwave or ultrasound energy, to a predetermined region of the chordae tendineae or other collagen-containing tissue, such as the female urethra or the esophagus near the sphincter. The device comprises a tubular catheter containing an energy conduit, such as a fiber optic cable, adapted for delivering thermal energy to the tissue. The tubular catheter also contain a stabilizing device, disposed at its distal end, such as an asymmetrically shaped balloon or a retractable flexible metal hook. With the distal end of the catheter device positioned within a human heart, application of thermal energy to the chordae tendineae results in a shrinkage of the chordae, providing a treatment for primary mitral valve regurgitation.

Device for treatment of atrioventricular valve regurgitation

Multi-fiber laser device for shrinking tissue

A lasing device for performing a myringotomy or like procedure is provided. The distal end portion of an optical fiber used to transmit a laser energy beam to the surgical site is covered with a disposable, removably mounted sheath, whose distal end is substantially transparent to the wavelength of laser energy being emitted through the optical fiber. Optionally, a relatively low power aiming beam can be emitted coaxially with the laser energy beam.

Laser devices for performing a myringotomy

A surgical device is provided for forming a channel through or into tissue utilizing both mechanical energy and laser energy. The device includes a needle for forming the first part of the channel. The needle has an open bore. Mounted within the bore is an optical fiber for emitting laser energy to form the balance of the channel.

User actuated laser energy device and procedure for forming a channel within tissue

A surgical device is provided for forming a channel through or into tissue utilizing radio-frequency electrical energy. The device includes a cannula having an open bore. Mounted within the bore is an insulated mono-polar electrical lead, the distal end of which is not insulated, for forming the channel by mechanically advancing through the tissue and emitting radio-frequency energy. Alternatively, the device can have bipolar electrical leads.

Growing community of inventors

Huntington Beach, CA, United States of America

Marvin P Loeb